Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-21

Clinical Trial Update: Effects of Stulln and Accommodative Training [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Stulln with accommodative training for accommodation disorder and visual fatigue has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stulln

Snippet

Sponsor: Pacific University | Conditions: Accommodation Disorder, Visual Fatigue | Phase 1, Phase 2 | Status: WITHDRAWN